Financhill
Back

MariMed 10K Form

Sell
28

MRMD
MariMed

Last Price:
0.15
Seasonality Move:
44.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive MRMD News And Ratings

See the #1 stock for the next 7 days that we like better than MRMD

MRMD Financial Statistics

Sales & Book Value

Annual Sales: $148.6M
Cash Flow: $-1.8M
Price / Cash Flow: 0
Annual Sales: $0.18
Price / Book: 0.82

Profitability

EPS (TTM): -0.04050
Net Income (TTM): $-14.13M
Gross Margin: $65.92M
Return on Equity: -19.9%
Return on Assets: -7%

MariMed Earnings Forecast

Key MariMed Financial Ratios

  • The Gross Profit Margin over the past 13 years for MRMD is 44.36%.
  • The Selling, General & Administrative Expenses for MRMD have been equal to 34.13% of Gross Profit Margin.
  • The Research & Development expenses have been 7.09% of Revenue.
  • The Interest Expense is -57.30% of Operating Income.
  • The Net Earning history of MRMD is -10.79% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 7 years.

MariMed Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: MRMD
Website: marimedinc.com

Debt

Debt-to-Equity Ratio: 1.09
Current Ratio: 1.27
Quick Ratio: 0.4

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MRMD Technical Analysis vs Fundamental Analysis

Sell
28
MariMed (MRMD) is a Sell

Is MariMed a Buy or a Sell?

  • MariMed stock is rated a Sell
    The current MariMed [MRMD] share price is $0.16. The Score for MRMD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.